UNJ.F The United Laboratories International Holdings Limited

Healthcare Pharmaceuticals Frankfurt Exchange
0.8700 EUR
Close of Nov 12, 2026
0.7500 1.45
Market cap
EUR 1.71B
P/E
29.0x
P/B
0.75x
ROE
12.0%
Dividend yield
3.82%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is UNJ.F undervalued?

Graham number
Price0.8700
Graham value0.8872
Discount1.9%

UNJ.F trades 1.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

The United Laboratories International Holdings Limited fundamental analysis

No fundamental analysis for The United Laboratories International Holdings Limited yet.

The United Laboratories International Holdings Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About The United Laboratories International Holdings Limited

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium prod…

Full company profile